{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:29:53Z","timestamp":1794547793370,"version":"4.9.1"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11,11]]},"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Psoriasis is a kind of chronic inflammatory skin disease characterized by erythema, skin hyperplasia, scales and keratinocyte hyperproliferation. Psoriasis Vulgaris, the most common kind of psoriasis, severely deteriorates the life quality of patients. Traditional Chinese Medicine (TCM) is a good choice for the treatment of psoriasis, which has been proved to be safe and effective, and may reduce the recurrence rate. In clinical practice, <jats:italic toggle=\"yes\">Liangxue Jiedu Runzhi<\/jats:italic> (LJR) ointment can effectively treat mild and moderate psoriasis with blood-heat syndrome, but there is a lack of evidence-based medical evidence. This trial aims to evaluate the efficacy and safety of LJR ointment for the treatment of mild and moderate psoriasis with blood-heat syndrome.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A multicenter, randomized, double-blind, placebo-controlled, and self-controlled clinical trial was carried out according to this paper. The symmetrical rashes of each subject were regarded as the target lesions and were randomly divided into a treatment group (LJR ointment group) and a control group (placebo group). The LJR ointment or placebo ointment were externally administered on bilateral symmetric rashes, twice a day for eight weeks. The follow-up examination was made for subjects every two weeks. The primary research finding was conveyed by Psoriasis Area and Severity Index (PASI) in 8 weeks. The secondary research finding includes adverse events.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>46 subjects undergo this research project. The difference between PASI scores of the target lesions in the treatment group and control group is statistically significant were in 8 weeks (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001). The percentage of PASI 75 in treatment group and control group were 48% and 15% in week 8, respectively (<jats:italic toggle=\"yes\">x<\/jats:italic>\n                                 <jats:sup>\n                                    2\n                                 <\/jats:sup>\u2005=\u200511.33, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). No severe adverse events were reported.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>LJR ointment was proved to have efficacy in the treatment of mild and moderate psoriasis with the blood-heat syndrome.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000031784","type":"journal-article","created":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T14:10:09Z","timestamp":1668694209000},"page":"e31784","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Liangxue Jiedu Runzhi ointment in the treatment of mild and moderate psoriasis with blood-heat syndrome: A double-blind randomized controlled trial"],"prefix":"10.1097","volume":"101","author":[{"given":"Yue","family":"Qiu","sequence":"first","affiliation":[{"name":"Department of Dermatology, Beijing Hospital of Traditional Chinese Medicine, Dongcheng District, Beijing, China"},{"name":"Beijing Miyun Hospital of Traditional Chinese Medicine, Miyun area, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weishu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Changzhi City Hospital of Traditional Chinese Medicine, Shanxi Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanru","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Beijing Traditional Chinese Medicine Hospital Shunyi Hospital, Shunyi District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwei","family":"Guo","sequence":"additional","affiliation":[{"name":"Beijing Longfu Hospital, Dongcheng District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Beijing Hospital of Traditional Chinese Medicine, Dongcheng District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibing","family":"Lan","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Beijing Gulou Hospital of Traditional Chinese Medicine, Dongcheng District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Beijing Hospital of Traditional Chinese Medicine, Dongcheng District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingna","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Beijing Hospital of Traditional Chinese Medicine, Dongcheng District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0200-4171","authenticated-orcid":false,"given":"Liyun","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Beijing Hospital of Traditional Chinese Medicine, Dongcheng District, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2018.03.018","article-title":"Anti-IL-12\/IL-23p40 antibody ameliorates dermatitis and skin barrier dysfunction in mice with imiquimod-induced psoriasis-like dermatitis","volume":"828","author":"Takahashi","year":"2018","journal-title":"Eur J Pharmacol"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/ijd.14864","article-title":"Global burden of psoriasis \u2013 comparison of regional and global epidemiology, 1990 to 2017","volume":"59","author":"AlQassimi","year":"2020","journal-title":"Int J Dermatol"},{"key":"R3-20250504","first-page":"48","article-title":"Progress in epidemiological investigation of psoriasis","volume":"20","author":"Huang","year":"2021","journal-title":"Diag Theory Pract"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2020.04.139","article-title":"The global, regional, and national burden of psoriasis in 195 countries and territories, 1990 to 2017: a systematic analysis from the Global Burden of Disease Study 2017","volume":"84","author":"Mehrmal","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaad.2015.02.1099","article-title":"Evaluating the economic burden of psoriasis in the United States","volume":"72","author":"Vanderpuye-Orgle","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/bjd.12393","article-title":"Topical treatments for chronic plaque psoriasis of the scalp: a systematic review","volume":"169","author":"Mason","year":"2013","journal-title":"Br J Dermatol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11655-009-0145-5","article-title":"Effect of Chinese herbal medicine combined with acitretin capsule in treating psoriasis of blood-heat syndrome type","volume":"15","author":"Zhang","year":"2009","journal-title":"Chin J Integr Med"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1080\/07391102.2020.1839562","article-title":"Novel chalcones derivatives with potential antineoplastic activity investigated by docking and molecular dynamics simulations","volume":"40","author":"Neto","year":"2022","journal-title":"J Biomol Struct Dyn"},{"key":"R10-20250504","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2021.103589","article-title":"Antiproliferative, genotoxic activities and quantification of extracts and cucurbitacin B obtained from Luffa operculata (L.) Cogn","volume":"15","author":"Galucio","year":"2022","journal-title":"Arabian J Chem"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1038\/s41598-022-08735-7","article-title":"Inflammasome NLRP3 activation induced by Convulxin, a C-type lectin-like isolated from Crotalus durissus terrificus snake venom","volume":"12","author":"Rego","year":"2022","journal-title":"Sci Rep"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1080\/07391102.2020.1821782","article-title":"In silico improvement of the cyanobacterial lectin microvirin and mannose interaction","volume":"40","author":"Lima","year":"2022","journal-title":"J Biomol Struct Dyn"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.toxicon.2021.02.015","article-title":"In silico analyses of toxicity of the major constituents of essential oils from two Ipomoea L. species","volume":"195","author":"da Silva","year":"2021","journal-title":"Toxicon"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"103084","DOI":"10.1016\/j.arabjc.2021.103084","article-title":"Evaluation of the genotoxicity and mutagenicity of isoeleutherin and eleutherin isolated from Eleutherine plicata herb. using bioassays and in silico approaches.","volume":"14","author":"Castro","year":"2021","journal-title":"Arabian J Chem"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/ph12010036","article-title":"In Silico study to identify new antituberculosis molecules from natural sources by hierarchical virtual screening and molecular dynamics simulations","volume":"12","author":"Pinto","year":"2019","journal-title":"Pharmaceuticals (Basel)"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/archderm.144.11.1457","article-title":"Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis","volume":"144","author":"Lin","year":"2008","journal-title":"Arch Dermatol"},{"key":"R17-20250504","first-page":"77","article-title":"Research progress on traditional Chinese medicine external treatment in the treatment of psoriasis vulgaris","volume":"10","author":"Lan","year":"2015","journal-title":"Jiangxi J Trad Chin Med"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"e20172","DOI":"10.1097\/MD.0000000000020172","article-title":"To explore the clinical efficacy of Traditional Chinese Medicine bath in the treatment of psoriasis vulgaris with blood-heat syndrome and its effect on related cytokines based on different temperature and different concentration","volume":"99","author":"Lin","year":"2020","journal-title":"Medicine (Baltim)"},{"key":"R20-20250504","first-page":"692","article-title":"Effect of Traditional Chinese Medicine plus narrow-band medium-wave ultraviolet B radiation on moderate-to-severe psoriasis vulgaris in a case series","volume":"39","author":"Li","year":"2019","journal-title":"J Tradit Chin Med"},{"key":"R21-20250504","first-page":"1018","article-title":"Effectiveness of flesh-moistening paste in psoriasis vulgaris patients with symptom pattern of blood stasis: a randomized and parallel-controlled trial","volume":"40","author":"Guo","year":"2020","journal-title":"J Tradit Chin Med"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jclinepi.2015.05.004","article-title":"CONSORT extension for reporting N-of-1 trials (CENT) 2015 Statement","volume":"76","author":"Vohra","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"R24-20250504","first-page":"265","article-title":"Interpretation of guidelines for psoriasis diagnosis and treatment in China (2018 edition)","volume":"40","author":"Shi","year":"2019","journal-title":"J Tongji Univ (Medical Ed)"},{"key":"R25-20250504","first-page":"213","article-title":"Guideline for the treatment of psoriasis (2008)","volume":"3","year":"2009","journal-title":"Chin J Dermatol"},{"key":"R26-20250504","first-page":"667","article-title":"Psoriasis diagnosis and treatment guidelines in China (2018 complete edition)","volume":"10","year":"2019","journal-title":"Chin J Dermatol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1080\/13696998.2019.1627362","article-title":"Developing a preference-based utility scoring algorithm for the Psoriasis Area Severity Index (PASI)","volume":"22","author":"Matza","year":"2019","journal-title":"J Med Econ"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-2133.1999.02963.x","article-title":"Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality","volume":"141","author":"Ashcroft","year":"1999","journal-title":"Br J Dermatol"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12906-017-1631-5","article-title":"Chinese herbal Pulian ointment in treating psoriasis vulgaris of blood-heat syndrome: a multi-center, double-blind, randomized, placebo-controlled trial","volume":"17","author":"Li","year":"2017","journal-title":"BMC Complement Altern Med"},{"key":"R30-20250504","first-page":"11","article-title":"Influence of angelica polysaccharide on the expression levels of PCNA in psoriasis-like lesions of guinea pigs","volume":"01","author":"Jing","year":"2008","journal-title":"Chin J Derm Venereo"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"153356","DOI":"10.1016\/j.phymed.2020.153356","article-title":"Novel Chinese Angelica polysaccharide biomimetic nanomedicine to curcumin delivery for hepatocellular carcinoma treatment and immunomodulatory effect","volume":"80","author":"Guo","year":"2021","journal-title":"Phytomedicine"},{"key":"R33-20250504","first-page":"5129","article-title":"Study on the mechanism of inhibition effect of shikonin on HaCaT cells proliferation induced by EGF","volume":"32","author":"Liu","year":"2017","journal-title":"China J Trad Chin Med Pharm"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.3892\/mmr.2020.11315","article-title":"Shikonin inhibits CEBPD downregulation in IL-17-treated HaCaT cells and in an imiquimod-induced psoriasis model","volume":"22","author":"Lan","year":"2020","journal-title":"Mol Med Rep"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/9035","article-title":"Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases","volume":"1","author":"Hoessel","year":"1999","journal-title":"Nat Cell Biol"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1074\/jbc.M002466200","article-title":"Indirubins inhibit glycogen synthase kinase-3 beta and CDK5\/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer\u2019s disease. A property common to most cyclin-dependent kinase inhibitors?","volume":"276","author":"Leclerc","year":"2001","journal-title":"J Biol Chem"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1161\/ATVBAHA.110.212654","article-title":"Indirubin-3\u2019-monoxime blocks vascular smooth muscle cell proliferation by inhibition of signal transducer and activator of transcription 3 signaling and reduces neointima formation in vivo","volume":"30","author":"Schwaiberger","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R39-20250504","first-page":"163","article-title":"Effects of Tufuling Yinhua Decoction on TNF-\u03b1, IL-8 and VEGF of patients with psoriasis vulgaris combined with blood heat syndrome","volume":"29","author":"Chen","year":"2013","journal-title":"Pharm Clin Chin Materia Medica"},{"key":"R40-20250504","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jdermsci.2012.05.008","article-title":"Indirubin, an acting component of indigo naturalis, inhibits EGFR activation and EGF-induced CDC25B gene expression in epidermal keratinocytes","volume":"67","author":"Hsieh","year":"2012","journal-title":"J Dermatol Sci"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"107229","DOI":"10.1016\/j.intimp.2020.107229","article-title":"Indirubin attenuates IL-17A-induced CCL20 expression and production in keratinocytes through repressing TAK1 signaling pathway","volume":"94","author":"Zhao","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"10841","DOI":"10.3390\/ijms221910841","article-title":"Skin barrier dysregulation in psoriasis","volume":"22","author":"Orsmond","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/jcm10020359","article-title":"Skin barrier function in psoriasis and atopic dermatitis: transepidermal water loss and temperature as useful tools to assess disease severity","volume":"10","author":"Montero-Vilchez","year":"2021","journal-title":"J Clin Med"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1038\/jid.2014.205","article-title":"Abnormal epidermal barrier recovery in uninvolved skin supports the notion of an epidermal pathogenesis of psoriasis","volume":"134","author":"Ye","year":"2014","journal-title":"J Invest Dermatol"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000489524","article-title":"Role of Skin pH in Psoriasis","volume":"54","author":"Bigliardi","year":"2018","journal-title":"Curr Probl Dermatol"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"s3","DOI":"10.36849\/JDD.589a","article-title":"ARTICLE: evolution of skin barrier science for healthy and compromised skin","volume":"20","author":"Haftek","year":"2021","journal-title":"J Drugs Dermatol"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00403-011-1136-x","article-title":"Abnormal aquaporin-3 protein expression in hyperproliferative skin disorders","volume":"303","author":"Voss","year":"2011","journal-title":"Arch Dermatol Res"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1042\/BC20040104","article-title":"Aquaporin-3 functions as a glycerol transporter in mammalian skin","volume":"97","author":"Hara-Chikuma","year":"2005","journal-title":"Biol Cell"},{"key":"R49-20250504","first-page":"179","article-title":"Evaluation of a skin protection cream for dry skin in patients undergoing narrow band UVB phototherapy for psoriasis vulgaris","volume":"146","author":"Pacifico","year":"2011","journal-title":"G Ital Dermatol Venereol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031784","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:04:15Z","timestamp":1746335055000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000031784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":45,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000031784","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,11]]}}}